Latest / Pharmacy Podcast Network / The NASP Specialty Pharmacy Expo RECAP Show | Part Three

Transcript

The NASP Specialty Pharmacy Expo RECAP Show | Part Three · Pharmacy Podcast Network

• 0:05
  Speaker 1: You are listening to the global network of podcasters dedicated
• 0:09
  Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
• 0:24
  Speaker 2: Hey there, Welcome to the NASP twenty twenty five here
• 0:32
  Speaker 2: at the gay Lord Rockies in Denver, Colorado. This is
• 0:35
  Speaker 2: an exciting time where we're bringing together thousands of people
• 0:40
  Speaker 2: focused on specialty pharmacy and impact on our patients. You're
• 0:44
  Speaker 2: not going to want to miss this. Stay tuned for
• 0:46
  Speaker 2: the coverage of the NASP twenty twenty five, brought to
• 0:50
  Speaker 2: you by the Pharmacy Podcast Network. Here with Jennifer Noonan
• 0:57
  Speaker 2: with Excessia Health at the NASP twenty twenty five. Jennifer,
• 1:01
  Speaker 2: why is this an important organization and conference to be
• 1:04
  Speaker 2: a part of.
• 1:06
  Speaker 3: Well, it's important for I think all specialty pharmacies across
• 1:11
  Speaker 3: the country just because of the standard that they uphold
• 1:15
  Speaker 3: people to, that they have such great educational opportunities. But
• 1:20
  Speaker 3: as you know, I'm not a pharmacist, and so I
• 1:22
  Speaker 3: think sometimes people wonder how did I end up in
• 1:25
  Speaker 3: this environment? And my background is nursing twenty five years
• 1:30
  Speaker 3: of patient facing. I worked about seventeen years in emergency
• 1:33
  Speaker 3: medicine and moved into hospice care, and in that role
• 1:38
  Speaker 3: started working in the pediatric hospice realm, which shouldn't probably exist,
• 1:44
  Speaker 3: but it does horrible. Yeah, but in that role I
• 1:47
  Speaker 3: learned way more than I ever thought I could about
• 1:51
  Speaker 3: the total destruction of families that have impactful, rare or
• 1:56
  Speaker 3: complex health conditions. And so I will, you know, all
• 2:00
  Speaker 3: always go back to learning about that. It doesn't matter
• 2:04
  Speaker 3: how much money they had or.
• 2:05
  Speaker 2: How well off they were.
• 2:06
  Speaker 3: If you start talking about treatments, they're in the tens
• 2:09
  Speaker 3: and hundreds of thousands of dollars. No one can get
• 2:12
  Speaker 3: through that and look the same on the other side.
• 2:17
  Speaker 3: I learned about my position or about EXCESSI a health
• 2:20
  Speaker 3: about four years ago, and I thought I knew a
• 2:22
  Speaker 3: lot twenty five years of nursing, right, I know a lot.
• 2:26
  Speaker 3: And my first day at EXCESSI recognized there's just a
• 2:29
  Speaker 3: much different type of.
• 2:31
  Speaker 4: Work and.
• 2:33
  Speaker 3: Needed to have a crash course in all things sp
• 2:38
  Speaker 3: And Sheila was one of the first people that I
• 2:41
  Speaker 3: met in my new role. We had a zoom call
• 2:43
  Speaker 3: and she told me all about NASP and immediately told
• 2:46
  Speaker 3: me about the conference or about the committees. So I
• 2:51
  Speaker 3: joined a committee and then I joined another committee, and
• 2:53
  Speaker 3: in that I made connections, real good solid connections with
• 2:57
  Speaker 3: lots of people with the same missionarious roles, and those
• 3:02
  Speaker 3: people helped me understand exactly what I needed to understand
• 3:07
  Speaker 3: in order to be more successful in creating programs for patients.
• 3:12
  Speaker 3: And after several years of just showing up for all
• 3:16
  Speaker 3: the committee meetings, inn ASP in their very heavy intention
• 3:22
  Speaker 3: of having a diverse and representative board, they asked if
• 3:27
  Speaker 3: I would join because they had not really had a
• 3:30
  Speaker 3: patient centered access point on the board. And so I
• 3:36
  Speaker 3: do like to brag about that. Sometimes our meetings can
• 3:39
  Speaker 3: be a little spirited, but it's because we have so
• 3:42
  Speaker 3: many different We have every angle you could think of,
• 3:45
  Speaker 3: and we don't always see from the same place. But
• 3:50
  Speaker 3: it's great to have all those different oppositional viewpoints to
• 3:57
  Speaker 3: come together and find the best possible place to land
• 4:00
  Speaker 3: where the patient and its providers benefits.
• 4:04
  Speaker 2: Jennifer, it's always wonderful to talk with you. We so
• 4:06
  Speaker 2: much appreciate you and the assistance and the sponsorship from
• 4:10
  Speaker 2: the Excessia Health team. Thank you so much.
• 4:12
  Speaker 3: Thanks Todd.
• 4:13
  Speaker 2: Hey, We'll be right back with more at the NASP
• 4:16
  Speaker 2: podcast here in Denver, Colorado.
• 4:22
  Speaker 5: Accessia Health a national charitable patient assistance organization is dedicated
• 4:26
  Speaker 5: to eliminating healthcare barriers for those with rare or chronic
• 4:30
  Speaker 5: health conditions through personalized case management, financial assistance, education, and
• 4:36
  Speaker 5: legal support. The organization provides more than copay relief. It
• 4:41
  Speaker 5: delivers a full spectrum of services that address the real
• 4:43
  Speaker 5: costs of care. Founded by patients for patients, Accessia Health
• 4:48
  Speaker 5: helps cover essential expenses like insurance, premiums, diagnostic testing, counseling
• 4:53
  Speaker 5: and therapy services, travel and more. Their inclusive outcomes focused
• 4:58
  Speaker 5: approach supports people throughout their healthcare journey. Learn how Excessia
• 5:02
  Speaker 5: Health is closing gaps and care and improving lives across
• 5:05
  Speaker 5: the country. Visit excessiahealth dot org today.
• 5:10
  Speaker 2: And we're back and Sean, you brought me another friend
• 5:14
  Speaker 2: of the industry, someone that's been part of the NASP
• 5:17
  Speaker 2: and support of the NASP. Introduced our guest.
• 5:20
  Speaker 6: Yeah, brilliant guy, friend Vi Simianu from Sphing Strategies. He
• 5:25
  Speaker 6: will tell you a little bit more about what he does.
• 5:27
  Speaker 2: That's SPINGS.
• 5:27
  Speaker 7: Thanks guys.
• 5:29
  Speaker 8: Yeah, we do operations of business development, building the highest
• 5:33
  Speaker 8: performers in specialty in specialty infusion across the nation. So
• 5:37
  Speaker 8: We've got all the card solutions from the time you
• 5:39
  Speaker 8: want to get into the time you want to get out.
• 5:41
  Speaker 8: I'll keep it short for that.
• 5:43
  Speaker 2: But that's why.
• 5:45
  Speaker 8: You know, NASPA has been wonderful because uh intimate convert,
• 5:49
  Speaker 8: intimate conversations, intimate conference.
• 5:53
  Speaker 7: You know, it's been really lucrative for us.
• 5:55
  Speaker 9: So we love the organization, We love the conference.
• 5:58
  Speaker 2: Sean, why is it important to contantly give back and
• 6:02
  Speaker 2: think of where do we meet as an entire sector
• 6:05
  Speaker 2: of healthcare within pharmacy, specialty pharmacy. Why is it part
• 6:09
  Speaker 2: of Why do you think it's important to be part
• 6:11
  Speaker 2: of a NEESP.
• 6:13
  Speaker 6: I mean this is really where this is where the
• 6:15
  Speaker 6: magic happens if you want to know about specialty and
• 6:17
  Speaker 6: what makes it special, like Sheilawa says, I mean, this
• 6:19
  Speaker 6: is really the heart of the specialty pharmacy community. And
• 6:23
  Speaker 6: I mean I was talking to a pharmacy student yesterday
• 6:25
  Speaker 6: here and you know he was just asking, you know
• 6:28
  Speaker 6: the same thing, like.
• 6:28
  Speaker 2: What should be looking for?
• 6:30
  Speaker 6: Are you doing? And it's like, dude, this is the
• 6:31
  Speaker 6: place to be if you have any interest in this
• 6:33
  Speaker 6: kind of career, this kind of field.
• 6:34
  Speaker 10: You know, there's no better, better organization to be a
• 6:36
  Speaker 10: part of VIC.
• 6:38
  Speaker 2: What's the evolution of specialty and where you're seeing AI
• 6:42
  Speaker 2: really be applicable and not just buzzwords but something that's
• 6:46
  Speaker 2: actually working.
• 6:47
  Speaker 8: Sure, we had a great talk on this yesterday. Our
• 6:51
  Speaker 8: panel discussion really kind of highlighted what you can do
• 6:53
  Speaker 8: think in specialty that constantly is on the bleeding edge,
• 6:58
  Speaker 8: the economics of it, you have to do more and
• 7:01
  Speaker 8: more with less and less. So I think we're AI.
• 7:04
  Speaker 8: Being the chair of the AI subcommittee for NASP, we
• 7:07
  Speaker 8: get to see a lot of the neat vendors and
• 7:10
  Speaker 8: the exhibitors out here that are doing some great things
• 7:12
  Speaker 8: with AI. Task automation, simple simple object character recognition, which
• 7:19
  Speaker 8: we talked about yesterday in terms of ocr tost speed
• 7:22
  Speaker 8: up intake, making sure that you're augmenting your staff to
• 7:26
  Speaker 8: really make it look like if you have ten people,
• 7:28
  Speaker 8: you've got more like one hundred to three hundred people.
• 7:31
  Speaker 8: So I think between intake, operations, automation, and analysis, I
• 7:37
  Speaker 8: think it's really important that we identify those three things.
• 7:40
  Speaker 8: You know, we had a talk on selling gene therapy
• 7:43
  Speaker 8: yesterday for patient identification. So I really am looking for
• 7:48
  Speaker 8: AI to do some wonderful things in terms of scrubbing
• 7:51
  Speaker 8: some unstructured data so we can find some more patients
• 7:55
  Speaker 8: and eligible patients for gene therapy.
• 7:59
  Speaker 6: Let's all from Todd bringing VIC here.
• 8:02
  Speaker 11: Right.
• 8:02
  Speaker 6: It seems like the theme of the day this year
• 8:04
  Speaker 6: is AI.
• 8:05
  Speaker 12: It is.
• 8:05
  Speaker 6: Looking around the room here, I think I'd say more
• 8:07
  Speaker 6: than half of these companies are are AI startups AI companies.
• 8:11
  Speaker 9: You know, Vix is one.
• 8:11
  Speaker 7: Of the first here. He's been.
• 8:13
  Speaker 6: He's had a booth here for years talking about AI,
• 8:15
  Speaker 6: like way before the other half of this room was
• 8:17
  Speaker 6: here talking about it. So if you want to cut
• 8:19
  Speaker 6: through the noise of like what's real, what's going on,
• 8:21
  Speaker 6: what's hype, what's demo?
• 8:22
  Speaker 10: You know, there's really no one.
• 8:23
  Speaker 7: Better to talk to about it than VIC.
• 8:24
  Speaker 6: So I'd be a great.
• 8:25
  Speaker 9: Person to I didn't pay him to say that.
• 8:28
  Speaker 2: It sounds like it, but this was a non Paya
• 8:30
  Speaker 2: commercial for VIC Strategies. Yeah, this has been a wonderful gathering.
• 8:38
  Speaker 2: We're in Denver, We're going to be in DC next year.
• 8:42
  Speaker 2: Sheila's team has just been dialed into what's important, policy, advocacy, education,
• 8:49
  Speaker 2: bringing people together. Sean, what is a challenge that you
• 8:53
  Speaker 2: see from your perspective in moving our industry forward. Is
• 8:56
  Speaker 2: there anything been standing out where you're like, hey, we
• 8:58
  Speaker 2: really need to to help more patients.
• 9:02
  Speaker 6: Yeah, I mean just connectivity between systems. It's been a
• 9:05
  Speaker 6: theme for years and years. Interoperability, Like the promise kind
• 9:08
  Speaker 6: of came and went in a way. It's like systems
• 9:10
  Speaker 6: are still disconnected. And you know, AI is another one
• 9:13
  Speaker 6: of these frontiers of all this promise and it's happening.
• 9:15
  Speaker 6: But I think the idea of all these systems being
• 9:18
  Speaker 6: interconnected and feeding into each other, you know, that was
• 9:20
  Speaker 6: the vision of it. A lot of standards came, and
• 9:22
  Speaker 6: it's just it's not the reality. I mean, you look
• 9:24
  Speaker 6: around and there's just so many bolt on applications and
• 9:27
  Speaker 6: both on startups, and it seems like everything's just pieced together.
• 9:30
  Speaker 6: And that's even within an organization. It's not even talking
• 9:32
  Speaker 6: about a pharmacy talking to a pharma partner or talking
• 9:35
  Speaker 6: to a provider or health system. Just within the pharmacy.
• 9:37
  Speaker 6: There's so many systems that are all just stitched.
• 9:39
  Speaker 7: Together and piece together.
• 9:41
  Speaker 6: So I just see that still being a challenge and
• 9:43
  Speaker 6: once all that can get solved, there's just so much
• 9:45
  Speaker 6: stuff that talk they talk about in these sessions that
• 9:46
  Speaker 6: could really come to life and really be possible with
• 9:49
  Speaker 6: better interoperability.
• 9:50
  Speaker 2: Well, that's also where JB Consulting comes in because you're
• 9:53
  Speaker 2: paying attention to some of the pitfalls of what's holding back,
• 9:57
  Speaker 2: especially pharmacies and moving forward. And that's what your clients
• 10:00
  Speaker 2: are there, the specialty pharmacies that are looking for efficiency,
• 10:03
  Speaker 2: and you're building APIs between systems and you're doing custom interfaces,
• 10:08
  Speaker 2: and I mean that's important to have an organization like
• 10:11
  Speaker 2: yours that's followed where specialty has been, where we're going
• 10:15
  Speaker 2: and how to get specialty pharmacies there faster.
• 10:18
  Speaker 12: Yeah.
• 10:18
  Speaker 6: I mean we've been connecting these systems for twenty years,
• 10:20
  Speaker 6: like anyway you're you're able to do it. So with
• 10:22
  Speaker 6: true interoperability, hopefully we won't have to be stitching them
• 10:25
  Speaker 6: together what we've been doing. But we've been here JB
• 10:27
  Speaker 6: for the last twenty years, like I said, doing this,
• 10:29
  Speaker 6: so yeah, we're helping connect them somehow.
• 10:33
  Speaker 2: Vic Sean, thank you so much for being part of
• 10:35
  Speaker 2: the NESP podcast. I appreciate you being here.
• 10:37
  Speaker 6: Can we throw in a quick plug for an ASP
• 10:39
  Speaker 6: and just say if anyone wants to join the Tech
• 10:41
  Speaker 6: Committee to reach out either to myself or to VIC
• 10:43
  Speaker 6: and specifically don't want to be on the AI subcomit.
• 10:45
  Speaker 2: Yes, get in while it's hot.
• 10:48
  Speaker 6: We might at the start a second one, but reach
• 10:51
  Speaker 6: out to myself or Vic or just anyone from the
• 10:52
  Speaker 6: ANASP team, anyone listening, So we'd love to have more
• 10:55
  Speaker 6: people join the group.
• 10:56
  Speaker 2: Excellent, Thank you, Thank you so much, Sad, thanks, Sean, Yeah,
• 10:59
  Speaker 2: thank you, right.
• 11:00
  Speaker 13: Thank you.
• 11:00
  Speaker 7: All.
• 11:05
  Speaker 5: Better patient outcomes start with the right technology partners. JB
• 11:08
  Speaker 5: Consulting helps pharmacies deliver superior clinical care and enhance patient
• 11:12
  Speaker 5: experiences through smart technology solutions. Our products help pharmaceutical manufacturers
• 11:17
  Speaker 5: improve patient access and build stronger pharmacy relationships. JB Consulting
• 11:22
  Speaker 5: where pharmaceutical expertise meets cutting edge technology. Visitjbconsulting dot com.
• 11:33
  Speaker 2: Kevin Kalumus here at the NASP Podcast twenty twenty five. Kevin,
• 11:37
  Speaker 2: Welcome to the show. Thanks so much for having me
• 11:39
  Speaker 2: and excited for NAS. Hey, you're excited for NAS. We
• 11:42
  Speaker 2: I'm excited to talk to you about your poster. Tell
• 11:45
  Speaker 2: our listeners a little bit about the work that you've
• 11:47
  Speaker 2: put in to put this research out.
• 11:50
  Speaker 14: So this is literally years of work coming together We've
• 11:52
  Speaker 14: had a lot of posters on AI validations in our tool.
• 11:55
  Speaker 14: We're literature software, so we're validating searching, the literature, screening,
• 11:59
  Speaker 14: and extracting. Is the first time we've ever brought it
• 12:01
  Speaker 14: all together down a validation from the very beginning to
• 12:03
  Speaker 14: the very end. So validating literature, search, screening, and extraction
• 12:06
  Speaker 14: so you can do instant literature review based on whatever
• 12:08
  Speaker 14: question you bring me.
• 12:10
  Speaker 2: So talk to us about how that applies to specialty
• 12:14
  Speaker 2: pharmacy specifically.
• 12:16
  Speaker 14: Great question, and I think that it actually applies throughout
• 12:18
  Speaker 14: the entire industry, but the very specifics for our growth here,
• 12:23
  Speaker 14: we actually came from academic research. That was my own background,
• 12:26
  Speaker 14: and then we moved into medical device and pharma and
• 12:28
  Speaker 14: that was the basis for understanding that you actually need
• 12:31
  Speaker 14: this data at every part of the pharmaceutical life cycle,
• 12:34
  Speaker 14: and you actually want that in all decision making periods.
• 12:36
  Speaker 14: So in specialty pharmacy, maybe the pharmacist themselves is not
• 12:40
  Speaker 14: doing literature driven research, but every decision along.
• 12:42
  Speaker 2: The way that gets you there.
• 12:43
  Speaker 14: In market access, in negotiating prices, everything centers around literature
• 12:48
  Speaker 14: based evidence because that drives your understanding of the patient burden.
• 12:51
  Speaker 14: It understands your It drives you understanding of the benefits
• 12:55
  Speaker 14: of a drug and also the costs of that drug.
• 12:57
  Speaker 2: Excellent. So could you see the being a resource for
• 13:01
  Speaker 2: specialty pharmacists that we're dealing with, Let's say a cancer
• 13:04
  Speaker 2: patient or HIV or something. Give us an example how
• 13:08
  Speaker 2: this might fit into there. So I love this use case.
• 13:11
  Speaker 14: I feel like it's a burgeoning one as we've made
• 13:13
  Speaker 14: our tool easier and easier being able to just research
• 13:16
  Speaker 14: what is the cutting edge in a certain discipline. The
• 13:18
  Speaker 14: literature is basically your place to go for trustable evidence
• 13:21
  Speaker 14: on drug performance, and so we're tracking that. My favorite
• 13:24
  Speaker 14: application of our software is actually getting updates on a daily,
• 13:27
  Speaker 14: weekly basis on any area. So if you're highly highly
• 13:29
  Speaker 14: invested in the HIV or cancer area and you want
• 13:31
  Speaker 14: to track that, that is something our software can enable.
• 13:34
  Speaker 2: All Right, a listener's listening. You've peaked their interest. How
• 13:37
  Speaker 2: do they reach out to? Where do they go? Do
• 13:38
  Speaker 2: you have a website or something?
• 13:39
  Speaker 14: We absolutely have a website that's nested dashnoledge dot com.
• 13:43
  Speaker 14: We're here at the We're actually part of the a
• 13:45
  Speaker 14: special poster session on AI so they can come to that.
• 13:48
  Speaker 14: If they're at an ask, but otherwise you can email
• 13:50
  Speaker 14: our support team if you wanted a demo, and we
• 13:51
  Speaker 14: even get free trials. So very happy to get people.
• 13:53
  Speaker 2: In nested dash knowledge knowledge dot com. Very good Kevin,
• 13:59
  Speaker 2: Hey Todd, thank you so much.
• 14:01
  Speaker 7: You all right.
• 14:17
  Speaker 15: Founded in twenty twelve, the NASP was established to represent
• 14:21
  Speaker 15: the rapidly growing specialty pharmacy sector in the United States,
• 14:25
  Speaker 15: unifying stakeholders across pharmacy manufacturers, distributors, and clinicians. Over the years,
• 14:30
  Speaker 15: the NASP has grown in membership and influence, expanding its
• 14:34
  Speaker 15: corporate and individual membership base to three thousand plus total
• 14:37
  Speaker 15: members and over two hundred corporate members across manufacturers, specialty pharmacies, PBMs,
• 14:43
  Speaker 15: technology vendors, and patient advocacy groups.
• 14:47
  Speaker 2: When I get to come the NASP, favorite part of
• 14:50
  Speaker 2: it is meeting new people, meeting up with Lee Pratt
• 14:53
  Speaker 2: from pro Chant. Lee, it's good to say good to
• 14:57
  Speaker 2: have you here on the show.
• 14:57
  Speaker 11: Well Todd, thanks for having me. Always excited to attend
• 15:01
  Speaker 11: the annual event here and super excited to get this
• 15:04
  Speaker 11: kicked off in Denver. Thanks for having us.
• 15:06
  Speaker 2: You're very welcome. The Pharmacy Podcast Network has loved working
• 15:10
  Speaker 2: with Sheila Arquette and the people at NASPRE used to
• 15:13
  Speaker 2: be called NEST, now they see NASP and a year
• 15:17
  Speaker 2: after year we've been here for the last five years.
• 15:20
  Speaker 2: It's been a celebration to really see twenty one hundred
• 15:24
  Speaker 2: attendees this year, up from nineteen hundred last year at
• 15:28
  Speaker 2: the conference. Why is it important to support the NASP.
• 15:32
  Speaker 2: Why are you guys here?
• 15:33
  Speaker 11: Yeah, great question. You know, first, you know, this is
• 15:36
  Speaker 11: my third time here. I feel like every time that
• 15:39
  Speaker 11: we are here continues to grow and Sheila and their
• 15:41
  Speaker 11: team do a great job. You know, we come for
• 15:44
  Speaker 11: a few reasons and love to support ANASP. One for
• 15:48
  Speaker 11: you know, the industry insights and the visibility and what's
• 15:52
  Speaker 11: shifting in the last year in the specialty pharmacy space.
• 15:56
  Speaker 11: And secondly for us to be able to get face
• 15:59
  Speaker 11: to face with with clients and prospective clients and providers
• 16:03
  Speaker 11: to kind of just see what the pains are out there,
• 16:05
  Speaker 11: what's going on where you know, what solutions are being
• 16:08
  Speaker 11: you know put out that weren't there a year ago.
• 16:11
  Speaker 11: So really providing those insights for us is just super
• 16:13
  Speaker 11: important for where we sit in the space.
• 16:16
  Speaker 2: There's a challenge that it's a reoccurring challenge. It happens
• 16:20
  Speaker 2: in my original space, long term care pharmacy. It's death.
• 16:24
  Speaker 2: It's the death of pharmacies and in the community retail
• 16:27
  Speaker 2: space because of PBM reform. And that is revenue cycle
• 16:31
  Speaker 2: management and how important that is to the lifeblood of organizations.
• 16:35
  Speaker 2: So talk to us about pro Chant and what your
• 16:38
  Speaker 2: mission here is at the NSP.
• 16:40
  Speaker 7: Yeah.
• 16:41
  Speaker 11: So our mission is essentially to make providers be able
• 16:44
  Speaker 11: to provide better patient care at the end of the day,
• 16:47
  Speaker 11: that's what it's all about. And when pharmacists are sitting
• 16:49
  Speaker 11: there focusing on revenue cycle instead of you know, what
• 16:53
  Speaker 11: they became a pharmacist to do, I think it really
• 16:56
  Speaker 11: you know, challenges the organization whether they're looking to grow
• 16:59
  Speaker 11: or really just treat those patients with the best care possible.
• 17:03
  Speaker 11: So pro Chant we sit in a unique space where
• 17:06
  Speaker 11: we're going to provide en to end revenue cycle management services,
• 17:09
  Speaker 11: you know, and take billing collections. And that's kind of
• 17:13
  Speaker 11: where we're going to be able to assist people that
• 17:15
  Speaker 11: are struggling with keeping up with staff.
• 17:17
  Speaker 9: You know, we can't.
• 17:18
  Speaker 11: I like to say there's a brain drain going on.
• 17:20
  Speaker 11: A lot of people exiting the space or uh, you know,
• 17:23
  Speaker 11: your training people and then they leave for another pharmacy
• 17:26
  Speaker 11: down the road, whatever that may look like. There's a
• 17:28
  Speaker 11: lot of challenges on the staffing side. And then you know,
• 17:31
  Speaker 11: once again it's complex when you're when you're talking and
• 17:33
  Speaker 11: take billing collections and different payers, different therapies, mixes, drugs,
• 17:37
  Speaker 11: et cetera. You know, we got to make sure that
• 17:39
  Speaker 11: our providers are getting those dollars back in the door.
• 17:43
  Speaker 2: So, Lee, something that's I have committed to as a
• 17:47
  Speaker 2: as a podcast that is representing our profession and bringing
• 17:52
  Speaker 2: providers together and building discussions that really build trust is
• 17:56
  Speaker 2: the validity of information. You came up with a report
• 18:00
  Speaker 2: to bring in some of that validity based on a
• 18:03
  Speaker 2: study that you have this new research and what that reveals.
• 18:07
  Speaker 2: Talk to me about that because I want the listeners.
• 18:10
  Speaker 2: There's going to be a shown in our show notes.
• 18:12
  Speaker 2: There's going to be a link to this report. This
• 18:13
  Speaker 2: report is extremely interesting. Kind of expand upon that for us.
• 18:17
  Speaker 9: Yeah, happy to do that.
• 18:18
  Speaker 11: So we partnered in a research study between specialty pharmacies
• 18:23
  Speaker 11: and home infusion providers. We I think it was over
• 18:26
  Speaker 11: one hundred decision makers that we kind of were asking
• 18:29
  Speaker 11: various different questions and that's how we were able to
• 18:32
  Speaker 11: build this report. And you know, what we're seeing is,
• 18:34
  Speaker 11: you know, seventy three percent of those providers or decision
• 18:37
  Speaker 11: makers came back and told us that they're unhappy with
• 18:40
  Speaker 11: current RCM services, whether they're outsourced or you know, currently
• 18:45
  Speaker 11: in house. They also are you know, same number there,
• 18:47
  Speaker 11: seventy three percent they're not collecting all the revenue that
• 18:50
  Speaker 11: they think they should be getting in the door, you know,
• 18:53
  Speaker 11: And from that, I think a big deal and what
• 18:56
  Speaker 11: we're seeing here and conversations that the first boot sessions
• 19:00
  Speaker 11: yesterday having a lot of great talks with people that
• 19:03
  Speaker 11: are now looking at new strategies. So whether that be
• 19:07
  Speaker 11: pairing with the outsourcing partner and you know, not going
• 19:10
  Speaker 11: fully outsourced, keeping some in house staff, there's various different
• 19:13
  Speaker 11: ways that people can go about doing that, and I
• 19:15
  Speaker 11: think that this study kind of shows the importance of
• 19:18
  Speaker 11: revenue cycle management, especially in this space.
• 19:22
  Speaker 2: All right, Lie, I'm listening to the show. You've piqued
• 19:24
  Speaker 2: my interest. I really want to understand how you might
• 19:27
  Speaker 2: impact my specialty pharmacy or at really any pharmacy listening in.
• 19:31
  Speaker 2: I want you to go to pro chant dot com
• 19:33
  Speaker 2: once again. That's pro pro chant cha n T dot com. Lee,
• 19:39
  Speaker 2: promise that you'll come back maybe on this weekend pharmacy
• 19:41
  Speaker 2: and we can dig into some other things that you're doing.
• 19:43
  Speaker 9: I would love to do that.
• 19:45
  Speaker 11: You know. We are just excited to be here at
• 19:48
  Speaker 11: an ASP and appreciate the opportunity to talk with you
• 19:50
  Speaker 11: and discuss all things revenue cycle with you know, different
• 19:53
  Speaker 11: providers of different sizes from anywhere from three million to
• 19:57
  Speaker 11: billion dollar organizations. We're able to be flex, will partner
• 20:00
  Speaker 11: and meet whatever needs they make me.
• 20:02
  Speaker 2: Might have got to keep that cash flowing where they
• 20:05
  Speaker 2: say cream cash rules everything around me. Play that.
• 20:11
  Speaker 11: Yeah, that'd be a great one. Appreciate you, Tod, Thanks
• 20:13
  Speaker 11: for having us.
• 20:16
  Speaker 16: Hi, this is Maintain.
• 20:18
  Speaker 12: I'm a pharmacist and CEO at Two Trees Consulting. You're
• 20:22
  Speaker 12: listening to an ASP podcast.
• 20:27
  Speaker 2: Hey there, we are here at the NASP. We keep
• 20:32
  Speaker 2: meeting up over a microphone. What I mean. You were
• 20:35
  Speaker 2: on a show a year ago or maybe even two seasons.
• 20:38
  Speaker 16: Ago, that is correct.
• 20:40
  Speaker 12: It was last year and I was very excited to
• 20:43
  Speaker 12: be on podcasts for the first time. So now returning
• 20:47
  Speaker 12: this year and it's really exciting to see you again
• 20:51
  Speaker 12: and reconnect with friends.
• 20:52
  Speaker 2: Oh, thank you so much. Why is it important to
• 20:55
  Speaker 2: be part of the NSP. What is it about this
• 20:59
  Speaker 2: show that you can come a bout.
• 21:01
  Speaker 16: I think it's the people.
• 21:03
  Speaker 12: And today at the general session with the speaker Caleb Spitler,
• 21:11
  Speaker 12: and he's a wonderful public speaker, and one thing that
• 21:15
  Speaker 12: he talked about is in the age of AI, what is.
• 21:19
  Speaker 16: The important part of us?
• 21:22
  Speaker 12: And he talked about connection, human connection, and I think
• 21:25
  Speaker 12: that is what I resonate with this conference is the
• 21:29
  Speaker 12: connection making new friends, is sharing experiences with colleagues and
• 21:36
  Speaker 12: keep on, you know, seeing clients are growing and doing great.
• 21:41
  Speaker 12: So I'm really really excited. And every time I come,
• 21:45
  Speaker 12: not only as an attendee, I now become a faculty
• 21:50
  Speaker 12: and this is my second year doing workshops and really
• 21:54
  Speaker 12: sharing experiences in the space, and part of me becoming
• 21:58
  Speaker 12: a consultant is real in my passion for teaching and
• 22:03
  Speaker 12: sharing and mentoring you generational leaders. So I really find
• 22:08
  Speaker 12: this as most exciting and I can relate and then
• 22:11
  Speaker 12: feel truly belong to this organization.
• 22:14
  Speaker 2: I love that there's passion behind that there's purpose. Talk
• 22:18
  Speaker 2: to about the consulting evolution. Are you blending things like
• 22:23
  Speaker 2: getting pharmacies your AC or creditor. Are you blending disease
• 22:27
  Speaker 2: state management specific consultancy. Talk to us about some of
• 22:30
  Speaker 2: the strengths.
• 22:31
  Speaker 16: Yeah. Absolutely.
• 22:32
  Speaker 12: My background is a pharmacists and working in hospitals and
• 22:37
  Speaker 12: PBMs and specialty pharmacies, so I have a lot of
• 22:41
  Speaker 12: knowledge and experience and really connecting the data.
• 22:44
  Speaker 16: So when I consult with our clients.
• 22:47
  Speaker 12: And they are going through an ACHC accualditation or IRAQ accualitation,
• 22:52
  Speaker 12: I can't really understand what you're going through, not only
• 22:56
  Speaker 12: be able to offer compliance tips, but also on the
• 23:00
  Speaker 12: operation side, on the IT side. So it's a total
• 23:05
  Speaker 12: solution and we get them through accuiditation, and then after
• 23:08
  Speaker 12: acquidation is the next step, how.
• 23:11
  Speaker 16: Do we grow what disease day should.
• 23:13
  Speaker 12: We venture into, and how can we bring the best
• 23:18
  Speaker 12: care to patients. So it's an ongoing collaboration and it's
• 23:22
  Speaker 12: wonderful to see clients thrive after accualidation.
• 23:27
  Speaker 2: Talk to me about the dreaded audit and how the
• 23:31
  Speaker 2: consultancy sets them up for success of being almost like
• 23:34
  Speaker 2: audit ready.
• 23:36
  Speaker 12: Yeah, and that's our job and we help clients and
• 23:39
  Speaker 12: when they come to us, and they think they have
• 23:43
  Speaker 12: everything in place where they are humble and know they're
• 23:46
  Speaker 12: what they're missing. So when we get into the needed,
• 23:50
  Speaker 12: greedy and the weeds of things, and that's where we
• 23:54
  Speaker 12: identify the workflows may not be implemented correctly and the
• 23:59
  Speaker 12: steps were missing. So we're able to put a solution
• 24:03
  Speaker 12: together and we conduct mack survey to make sure that
• 24:07
  Speaker 12: customers are ready.
• 24:08
  Speaker 16: We actually just went through.
• 24:10
  Speaker 12: Accreditation today and there's only one deficiency and we're really
• 24:15
  Speaker 12: proud of the results. And in fact, our customers were
• 24:20
  Speaker 12: able to get them through accreditation cycle fairly quickly, so
• 24:23
  Speaker 12: a shc our quickest record was thirty eight business days
• 24:29
  Speaker 12: and then you'req was under six months. So we're really
• 24:33
  Speaker 12: proud of our results. But results, it's important. It's probably
• 24:39
  Speaker 12: one most important thing.
• 24:40
  Speaker 16: They hire us. They want to get accredited. But what most.
• 24:46
  Speaker 12: Exciting and rewarding is building connections with these people. Were
• 24:51
  Speaker 12: actually in the trenches with them, so we're not just
• 24:54
  Speaker 12: saying okay, test you know, test driver, and you gotta
• 24:57
  Speaker 12: have to get this thing done. Yes, of course, but
• 25:00
  Speaker 12: at the core of things, they know that we got
• 25:02
  Speaker 12: their back and we are going through this together. If
• 25:05
  Speaker 12: there are deficient and something we're rolling up our sleeves
• 25:08
  Speaker 12: and getting a jet. So building trust, building partnership, and
• 25:15
  Speaker 12: this is a long journey that we are invested in,
• 25:18
  Speaker 12: and we're investing in our customers and investing in ultimately
• 25:22
  Speaker 12: our patients.
• 25:23
  Speaker 2: All Right, if a listener is listening in, they're having
• 25:26
  Speaker 2: some issues, they want some more information, give them your
• 25:29
  Speaker 2: website so they can reach out to you.
• 25:31
  Speaker 12: Www. The number two chose Consulting. My phone number is
• 25:36
  Speaker 12: my cell phone number. Every signature has my cell phone
• 25:40
  Speaker 12: number sixty six three four eight four one seven nine,
• 25:45
  Speaker 12: so they can find me on the website or they
• 25:47
  Speaker 12: can call me, text me, email me. I pretty much
• 25:53
  Speaker 12: twenty four seven on. Just like all the specialty farmers,
• 25:56
  Speaker 12: just have to be on call. Twenty four to seven.
• 25:59
  Speaker 2: Yes, two Tree Consulting, Thank you so much for being
• 26:02
  Speaker 2: here again. This is great.
• 26:03
  Speaker 16: Thank you very much, Todd, Thank you.
• 26:09
  Speaker 2: Hey. Shout out to our specialty pharmacists and pharmacy owners
• 26:13
  Speaker 2: and pharmacy operators out there concentrating on rare disease, specialty
• 26:18
  Speaker 2: pharmacy specific disease state management. Do understand what the NASP
• 26:23
  Speaker 2: does in the power that it brings to our profession,
• 26:27
  Speaker 2: the protections that it brings, the education that it brings.
• 26:30
  Speaker 2: Federal and state advocacy, Government Affairs Committee workshops, grassroots advocacy
• 26:36
  Speaker 2: education including abstract and poster programs. The CMRO, a NASP partner,
• 26:44
  Speaker 2: Journal Education centered Presenter, Educational Committee and work groups. The
• 26:49
  Speaker 2: NASP is leading the Certified Specialty Pharmacist the CSP credentials.
• 26:56
  Speaker 2: Look into the NASP, reach out to one of theirs.
• 27:00
  Speaker 2: We're excited to be here at the NASP. Twenty twenty
• 27:03
  Speaker 2: five NASP Board member Nick Kala. Nick, you're a fellow
• 27:09
  Speaker 2: Pittsburgher too, right, Yes, I am goes the oers. Not
• 27:12
  Speaker 2: so much today.
• 27:13
  Speaker 9: Oh, not a good day today.
• 27:14
  Speaker 2: It wasn't a good day, Nick. Gene and cell therapy
• 27:18
  Speaker 2: is still a mystery in many ways. There's there's such
• 27:21
  Speaker 2: an expansion and innovation of that, and you had a
• 27:24
  Speaker 2: workshop on that today. I wanted you to share some
• 27:26
  Speaker 2: of that with our listeners listening to the NASP podcast.
• 27:30
  Speaker 17: So today we basically spend a day speaking about selling
• 27:34
  Speaker 17: gene therapy. There's quite a few coming to market. The
• 27:38
  Speaker 17: pipeline probably has well over eighty in development in some way,
• 27:43
  Speaker 17: shape or form, weed or seeing or working with several
• 27:46
  Speaker 17: roods products today. You know, to this point, when you
• 27:50
  Speaker 17: look at specialty pharmacy, they really we've been a distributor
• 27:54
  Speaker 17: of the product, the logistics coordinator of the product. Now
• 27:59
  Speaker 17: again it sounds simple.
• 28:00
  Speaker 9: But it isn't. In this particular space.
• 28:02
  Speaker 17: You have a product's being manufactured, sometimes for a group
• 28:07
  Speaker 17: of patients, sometimes specifically for a patient, depending on the.
• 28:10
  Speaker 9: Type of seller gene therapy we're working with.
• 28:13
  Speaker 17: Once that's manufactured, is usually a very low excursion on
• 28:18
  Speaker 17: that product, or typically refrigerated and or in a cryogenic state.
• 28:25
  Speaker 17: Sometimes we're actually working with one product now that is
• 28:28
  Speaker 17: actually in Warran chain state. So the logistics is where
• 28:32
  Speaker 17: we've been and it's really the taking into the product,
• 28:36
  Speaker 17: doing the benefit investigation, etc. The patient support whatever is needed,
• 28:42
  Speaker 17: and then from there sending it off to the site
• 28:46
  Speaker 17: of administration.
• 28:48
  Speaker 2: Now its time has gone by.
• 28:49
  Speaker 3: Here.
• 28:50
  Speaker 17: What we've gotten into is more and more these products
• 28:53
  Speaker 17: are going to go into more of a chronic type
• 28:55
  Speaker 17: of therapy. As they go into those chronic therapies, especially pharmacy,
• 29:00
  Speaker 17: I think in my mind, is going to play even
• 29:01
  Speaker 17: more a role in managing the patient from a clinical perspective. Again,
• 29:05
  Speaker 17: this is new into celling gene space, but I do
• 29:08
  Speaker 17: see it coming down the road. And then I think
• 29:10
  Speaker 17: the other place that we're going to see and things
• 29:12
  Speaker 17: that were touched upon during the workshops today is early
• 29:15
  Speaker 17: around outcome studies and really gathering the information needed to
• 29:20
  Speaker 17: actually do an outcome study or helping to facilitate gathering
• 29:25
  Speaker 17: the information and make that happen.
• 29:27
  Speaker 2: I always think of the splitting of hairs of specialists
• 29:30
  Speaker 2: and pharmacists that focus on very specific diseases and become
• 29:34
  Speaker 2: a specialist in HIV or oncology or something in selling
• 29:39
  Speaker 2: gene therapy. Is there disease states that the science is
• 29:43
  Speaker 2: leaning towards or having more success in one specific disease
• 29:47
  Speaker 2: state versus something else.
• 29:50
  Speaker 17: I think what we've seen, at least in my experience
• 29:52
  Speaker 17: in the neurology space, pediatric neurology especially, I think that's
• 29:57
  Speaker 17: where we've seen the majority of quote unquote success at
• 30:01
  Speaker 17: this point in time. So you have products like zolgenzma
• 30:04
  Speaker 17: from the Varius, and we also have products from elevenus
• 30:07
  Speaker 17: from Surrepta. It's had some other bad us at this point,
• 30:11
  Speaker 17: but it had helped the number of patients up to
• 30:13
  Speaker 17: this point. And then you also look in the hemophilia space,
• 30:18
  Speaker 17: there are some gene therapy that have helped at this
• 30:20
  Speaker 17: point a small group of patients, although I think it's.
• 30:22
  Speaker 2: Growing over time.
• 30:24
  Speaker 17: And then if you look in the hematology space with
• 30:26
  Speaker 17: sickle cell anemia, there's an area I think where you're
• 30:29
  Speaker 17: going to see a great degree of success with patients
• 30:32
  Speaker 17: with these products. Again, they're very specific to that patient.
• 30:36
  Speaker 17: They have a long incubation period, so a patient is
• 30:40
  Speaker 17: often waiting eight to nine months, but then once you
• 30:43
  Speaker 17: do get them onto the therapy or administerive therapy, at
• 30:46
  Speaker 17: that point you've seen some very positive ressaults.
• 30:50
  Speaker 2: Nick, how is or seeing reaching patients. Are you working
• 30:53
  Speaker 2: with health systems, are you working with specialist physicians that
• 30:56
  Speaker 2: are focusing on a specific disease state. How does Oursini
• 31:01
  Speaker 2: kind of build its business in patient care?
• 31:05
  Speaker 17: It's kind of all the above, todd everything that you
• 31:07
  Speaker 17: just mentioned. So it's really focused on in our world,
• 31:11
  Speaker 17: the provider and really those providers and allowing them or
• 31:15
  Speaker 17: giving them an avenue where they don't have to take
• 31:17
  Speaker 17: on the financial burden of a very expensive medication, and
• 31:21
  Speaker 17: then allowing this specialty pharmacy to really handle that part
• 31:24
  Speaker 17: of it and then, as we mentioned earlier, coordinating logistics
• 31:28
  Speaker 17: to get that to the site of administration. We partner
• 31:32
  Speaker 17: quite a bit with the payer community in educating them
• 31:36
  Speaker 17: on what selling chine therapies are and then really working
• 31:39
  Speaker 17: with the appropriate folks within those particular payers to really
• 31:44
  Speaker 17: get the product you approved.
• 31:47
  Speaker 9: For a particular patient.
• 31:49
  Speaker 17: And then in our world, we also work quite a
• 31:51
  Speaker 17: bit with the patient themselves, shepherding them through the process,
• 31:55
  Speaker 17: working as the patient advocacy teams in terms of really
• 31:59
  Speaker 17: achieved in the desired effect and making sure that patient
• 32:02
  Speaker 17: isn't lost in the shuffle as you're trying to get
• 32:05
  Speaker 17: the therapy ready for them. So really that's our focus
• 32:08
  Speaker 17: is how we handle the patient, the provider, and the payer,
• 32:12
  Speaker 17: which are all integral parts of making this happen.
• 32:16
  Speaker 13: Nick.
• 32:16
  Speaker 2: I love when I get a chance to interview you
• 32:18
  Speaker 2: and talk to you and bring updates to us. Appreciate
• 32:21
  Speaker 2: you being on the NSP podcast.
• 32:24
  Speaker 9: Todd always a pleasure.
• 32:25
  Speaker 2: Thank you.
• 32:26
  Speaker 9: I have a great day.
• 32:30
  Speaker 18: Hi, this is Redconner with Kyler Permanente and you're listening
• 32:33
  Speaker 18: to that ANSP podcast.
• 32:37
  Speaker 2: Read NASPA twenty twenty five. It's so good to see you.
• 32:41
  Speaker 13: Good to see you again.
• 32:42
  Speaker 2: All right, So you've become involved with NASP's certification. What
• 32:47
  Speaker 2: that means for our profession. Talk to us about the
• 32:51
  Speaker 2: involvement the what you've learned by being part of that,
• 32:54
  Speaker 2: and what that means for industry.
• 32:56
  Speaker 18: I'm glad you've asked, because you know we've I've been
• 32:58
  Speaker 18: on the board now for about sixty and have various roles.
• 33:02
  Speaker 18: I got CSB certified in twenty fifteen. I was number
• 33:05
  Speaker 18: one fifty one and we're at two thousand now. Oh wow,
• 33:07
  Speaker 18: and we have a ninety five percent retention rate, so
• 33:09
  Speaker 18: it shows you it's growing, even though it's in this
• 33:11
  Speaker 18: specially pharmacy community, a something that's reputable, valuable, and worth reviewing,
• 33:16
  Speaker 18: and the board of directors and those objective information might
• 33:19
  Speaker 18: support that. But work in the SPC booth for the
• 33:21
  Speaker 18: last hour. Everyone's coming up prepared. They're rare, they're sharing
• 33:25
  Speaker 18: case and a new studies of how it's helping them.
• 33:27
  Speaker 13: They're patients, the payer and all stakeholders.
• 33:30
  Speaker 2: Grade you've shared with me with the expansion of your
• 33:34
  Speaker 2: own organization, the successes that you've experienced. I wanted to
• 33:38
  Speaker 2: jumped into automation. I may want to talked to you
• 33:42
  Speaker 2: about AI and you paused me and you said, you
• 33:45
  Speaker 2: know what, the aspect of the part of care that
• 33:47
  Speaker 2: doesn't get enough you know talking about, is the holistic
• 33:51
  Speaker 2: part of the person, the patient venem of themselves. If
• 33:55
  Speaker 2: they're not getting the care that they want because they're
• 33:58
  Speaker 2: an African American community that doesn't focus enough on sickle
• 34:01
  Speaker 2: cell or something happening in women's health, talk to us
• 34:06
  Speaker 2: about that side of special Partmacy.
• 34:08
  Speaker 18: Thank you, Todd, and I do think it is a
• 34:11
  Speaker 18: great question to ask at our hospital chain right now
• 34:13
  Speaker 18: in his Care Experience week, And as a nonprofit, we're
• 34:17
  Speaker 18: really only providing memberships for financial leading Burston as a
• 34:21
  Speaker 18: health planned hospital physician group.
• 34:23
  Speaker 13: So expansion is where you can gain more members, especially
• 34:26
  Speaker 13: if we're.
• 34:26
  Speaker 18: Already saturated in California like we are, and I work
• 34:29
  Speaker 18: in northern California.
• 34:30
  Speaker 13: So a few years ago we got guys in Grow
• 34:32
  Speaker 13: and Rising Health.
• 34:33
  Speaker 18: We just got eighty thousand members last week and Nevada incredible.
• 34:36
  Speaker 13: It's showing people want our integrated care.
• 34:39
  Speaker 18: We talk about all the prior afts that some fragmented
• 34:42
  Speaker 18: parts of our healthcare pharmacy ecosystem experience, but when you're
• 34:45
  Speaker 18: on a formulare and your own payer and your own provider,
• 34:47
  Speaker 18: and you're at your own hospitals and your own physician group.
• 34:50
  Speaker 18: You can focus less on bureaucracy and more on the patient.
• 34:54
  Speaker 13: I look at the outcomes for our patients.
• 34:56
  Speaker 18: I look at the people, and I look at the process,
• 34:57
  Speaker 18: and the outcomes will come when you re exam I'm
• 35:00
  Speaker 18: in and revitalize and make process improvements in those two categories.
• 35:04
  Speaker 13: And the last thing is by people. I look at
• 35:06
  Speaker 13: the providers.
• 35:07
  Speaker 16: So it could be.
• 35:07
  Speaker 18: Especially pharmacists as well as the patient.
• 35:10
  Speaker 13: They both need to support.
• 35:12
  Speaker 2: Let's talk about the future of our specialty pharmacists and
• 35:16
  Speaker 2: getting our p fours in pharmacy schools understanding that specialty
• 35:20
  Speaker 2: pharmacy can become a whole career special reality for them.
• 35:24
  Speaker 2: At what point of a someone's career that is interested
• 35:27
  Speaker 2: in dialing into HIV or some blood disorder, when do
• 35:31
  Speaker 2: you bring them that, Hey, you have an opportunity to
• 35:34
  Speaker 2: get a certified specialty pharmacist track to really dial in
• 35:39
  Speaker 2: and really understand it.
• 35:41
  Speaker 18: And you asked an excellent question, because when I was
• 35:42
  Speaker 18: in pharmacy school, there was no classes about specially pharmacy, let.
• 35:45
  Speaker 13: Alone very few jobs.
• 35:47
  Speaker 18: We serve thirteen million members with Kiser Permanente and we
• 35:49
  Speaker 18: have one specialty pharmacy, so it's not going to be
• 35:52
  Speaker 18: a lot of opportunity for it, but there is opportunity
• 35:54
  Speaker 18: to do specially pharmacy like roles. You might be in
• 35:57
  Speaker 18: a job or a quarter of your day or a
• 35:58
  Speaker 18: third or day is doing it, and over time you can.
• 36:01
  Speaker 13: Build affinity towards that workflow.
• 36:03
  Speaker 18: If the complex follow up that allows you to provide
• 36:05
  Speaker 18: high touch, high quality care and you can leverage those
• 36:08
  Speaker 18: hours in two applying for the Certified Specialty Pharmacist credential,
• 36:11
  Speaker 18: I think what's nice about the CSP is it can
• 36:14
  Speaker 18: serve the person the P four going you know, or
• 36:16
  Speaker 18: maybe a new grad, give them a track to look
• 36:18
  Speaker 18: forward to continued learning. Just like anything in life. You
• 36:22
  Speaker 18: can continue learning about disease states. You may not have
• 36:24
  Speaker 18: experience with as an intern or whatever job you landed
• 36:26
  Speaker 18: after graduation, but it will help you get become well rounded,
• 36:29
  Speaker 18: more confident, so you provide better care and increase your
• 36:32
  Speaker 18: business because of increase patient return, all stakeholders.
• 36:35
  Speaker 13: Your company people are thriving.
• 36:37
  Speaker 18: People appreciate it, so internally that is one big aspect
• 36:40
  Speaker 18: that's providing value. Second, look at all the board of pharmacies.
• 36:43
  Speaker 18: I know in my state I'm an advanced practice pharmacist.
• 36:46
  Speaker 18: You look at residency, you look at a certification, you
• 36:49
  Speaker 18: look at years of experience and specialty, and you can get,
• 36:52
  Speaker 18: depending on your board of Pharmacy in your state, enhanced
• 36:55
  Speaker 18: autonomy as a pharmacist to initiate, adjust, monitor, you know,
• 36:59
  Speaker 18: and disc continue treatment. So especially pharmacists P four's looking
• 37:03
  Speaker 18: to what they can do. They don't necessarily have to
• 37:05
  Speaker 18: go straight to a specially pharmacy, but find a platform,
• 37:08
  Speaker 18: especially medications are being dispensed and prescribed. Getting that experience,
• 37:12
  Speaker 18: it's something you want to do scale from there.
• 37:14
  Speaker 11: Read.
• 37:15
  Speaker 2: Thank you so much for sharing the insights on the
• 37:17
  Speaker 2: NSP twenty twenty five. Look forward to seeing you in Baltimore.
• 37:21
  Speaker 13: For twenty twenty. Here we go, buddy, all right, thank you,
• 37:24
  Speaker 13: take care.
• 37:29
  Speaker 2: Richard Brooke back the NASP podcast. Is great to see you.
• 37:34
  Speaker 4: Oh, it's always a pleasure to spend time with you,
• 37:36
  Speaker 4: Todd and learn so much about the different people who
• 37:38
  Speaker 4: come through the podcast.
• 37:40
  Speaker 2: Yeah, that's what I like about this. It's one of
• 37:42
  Speaker 2: the ways I learn about our industry and what's happening
• 37:45
  Speaker 2: in the differentiation between one sector and another. You've been
• 37:48
  Speaker 2: part of specialty pharmacy for quite some time and support
• 37:52
  Speaker 2: the NASP. Talk to us about things that you're working
• 37:54
  Speaker 2: on right now. Well, first, let me just say I've
• 37:57
  Speaker 2: been pleased to be here at this Meetia. NASP has
• 38:00
  Speaker 2: got the biggest attendance, as I'm sure you've known and noticed. Today,
• 38:04
  Speaker 2: we've got more posters and abstracts.
• 38:06
  Speaker 4: I'm going to talk a little bit about some of
• 38:08
  Speaker 4: my observations on that and some of my other observations.
• 38:11
  Speaker 9: On specialty pharmacy.
• 38:12
  Speaker 4: Excellent when I'm not volunteering for NASS, but I do
• 38:15
  Speaker 4: run a company called Better Health Worldwide and we do
• 38:17
  Speaker 4: research and some of this is fed into.
• 38:21
  Speaker 9: What I'm going to talk about today.
• 38:23
  Speaker 4: So you know, as I was looking at the posters
• 38:25
  Speaker 4: today and I went to a couple of sessions, we're
• 38:28
  Speaker 4: seeing a lot on biosimilars. Yeah, as to be expected,
• 38:31
  Speaker 4: and we know now that finally the ice dam is
• 38:35
  Speaker 4: broken and we're getting more biosimilars on the market and
• 38:39
  Speaker 4: used than we ever did before.
• 38:40
  Speaker 9: But it's not equal across the boards.
• 38:43
  Speaker 4: There are some categories, for instance, in cancer, some of
• 38:46
  Speaker 4: the biosimilar adoption has really taken off, Lantis really taken off.
• 38:52
  Speaker 4: Yet we look at some of the immuno logic drugs
• 38:55
  Speaker 4: and there's been a little bit of a.
• 38:57
  Speaker 9: Pushback on them. In fact, if you've been following the
• 39:01
  Speaker 9: news as I know you.
• 39:02
  Speaker 4: Do outside of the podcast news, we see a lot
• 39:06
  Speaker 4: of things about how some of the big PBMs in
• 39:08
  Speaker 4: the US have contracted with one particular biosimilar and that
• 39:14
  Speaker 4: might not be the best or most economical biosimilar. So
• 39:17
  Speaker 4: I think we're seeing the movement here. But we also
• 39:21
  Speaker 4: noticed that the legislative reform is actually targeting a lot
• 39:24
  Speaker 4: of those PBMs, and I think it's going to be
• 39:26
  Speaker 4: interesting to see in the coming months and years what
• 39:29
  Speaker 4: happens as we maybe eliminate PBMs.
• 39:33
  Speaker 9: It's been a big call for it. I was fortunate
• 39:37
  Speaker 9: or unfortunate and earlier.
• 39:38
  Speaker 4: In my career to work for a PBM, and I
• 39:40
  Speaker 4: got to learn a lot about what PBMs do. And
• 39:42
  Speaker 4: they make money, that's clearly what they do, but are
• 39:45
  Speaker 4: they really giving us better patient care or are they
• 39:48
  Speaker 4: giving the best plans and the costs to the insurers
• 39:52
  Speaker 4: and the payers that are actually out there.
• 39:54
  Speaker 9: So I think that remains to be seen.
• 39:56
  Speaker 4: But in the case of biosimilars where I started there
• 40:00
  Speaker 4: that adoption in some categories and some where I think
• 40:04
  Speaker 4: that the PBMs are actually slowing down the adoption as
• 40:06
  Speaker 4: opposed to any biosimilar that's available there.
• 40:09
  Speaker 2: So what else have you seen in the research that
• 40:13
  Speaker 2: you've done. You have an interesting advantage where you're coupling
• 40:17
  Speaker 2: so much information about what's happening in the marketplace. Talk
• 40:21
  Speaker 2: to us more about some of the projects you've worked on.
• 40:24
  Speaker 4: Okay, so I have to limit myself to projects that
• 40:26
  Speaker 4: are publicly disclosable. I think one of the things we
• 40:31
  Speaker 4: keep getting calls on right now is the evolving US landscape.
• 40:37
  Speaker 4: You know, I go to a lot of international meetings,
• 40:39
  Speaker 4: and I was at the International Society of pharmaco Economics
• 40:43
  Speaker 4: and Outcomes Research in May, just as President Trump was
• 40:47
  Speaker 4: announcing some of his planned reforms.
• 40:51
  Speaker 9: Most favored nation pricing. Why are we going to be.
• 40:54
  Speaker 4: Discounting prices to the Europeans that we're not paying for here?
• 40:58
  Speaker 4: And you know, as an American, I'm actually in favor.
• 41:01
  Speaker 9: Of some of that.
• 41:03
  Speaker 4: You know, we see the people in Europe Germany where
• 41:06
  Speaker 4: they have a high reference pricing scheme really adamant saying, wait,
• 41:11
  Speaker 4: you're going to raise our prices. And I think this
• 41:14
  Speaker 4: is really a matter of how do we equate prices.
• 41:16
  Speaker 4: If you're gonna have a reference price within your country,
• 41:18
  Speaker 4: well maybe it should be a reference price around the world.
• 41:21
  Speaker 6: Now.
• 41:21
  Speaker 4: I think we'd hope as a society and people that
• 41:26
  Speaker 4: this reference pricing reassessment would lower prices. I'm not sure
• 41:32
  Speaker 4: that's ever going to be the case. I don't think
• 41:34
  Speaker 4: we ever see that clawback on pricing, So I think
• 41:36
  Speaker 4: it remains to be seen what happens in the future here.
• 41:40
  Speaker 4: But I think that we also have been noticing in
• 41:44
  Speaker 4: our research and we have a couple of posters here
• 41:47
  Speaker 4: about caregivers, right, the unforgotten people, the unpaid caregivers. God forbid,
• 41:52
  Speaker 4: your spouse or child get sick, what happens to you?
• 41:55
  Speaker 4: And we pay a lot of lip service to it.
• 41:57
  Speaker 7: But a lot of.
• 41:57
  Speaker 4: Companies, a lot of insurers are so focused on the
• 42:01
  Speaker 4: employee the patient, they don't really think about the bigger picture.
• 42:05
  Speaker 4: Most of the data that we work with comes from
• 42:07
  Speaker 4: an employer group. So if you're working for an employee er,
• 42:10
  Speaker 4: they generally cover the family, so they care that not
• 42:14
  Speaker 4: only does the patient get treated, but what's the impact
• 42:18
  Speaker 4: on the caregiver or the spouse or the parent, Especially
• 42:22
  Speaker 4: with a young child. You know who's going to take
• 42:25
  Speaker 4: that kid to the doctor. It's going to be someone
• 42:27
  Speaker 4: And I think that we need to see happen more.
• 42:30
  Speaker 4: The posters we have are on Alzheimer's disease and Parkinson's
• 42:34
  Speaker 4: and people said to me when we started this initiative,
• 42:37
  Speaker 4: are those really employee based conditions? Aren't those all Medicare?
• 42:41
  Speaker 4: And that's the assumption that these are age related conditions,
• 42:45
  Speaker 4: But we all know that as you get a new
• 42:47
  Speaker 4: therapy to market, as we've seen several in the Alzheimer's
• 42:50
  Speaker 4: disease space, these products.
• 42:52
  Speaker 7: Tend to come with a.
• 42:55
  Speaker 4: Disclaimer that say they work better for mild patients. So
• 42:58
  Speaker 4: we're actually seeing is patients going to the doctor saying,
• 43:01
  Speaker 4: you know, I think I got Alzheimer's coming on, and
• 43:04
  Speaker 4: can I get this drug? And there's a prior ofth
• 43:06
  Speaker 4: requirement and the sps have been graded in forcing those
• 43:09
  Speaker 4: and processing that and taking it forward. But to get
• 43:13
  Speaker 4: to that prescription, you need that diagnosis. And I always
• 43:16
  Speaker 4: think about Alzheimer's because having worked on Alzheimer's disease research
• 43:20
  Speaker 4: since the eighties. I think back and I can actually
• 43:23
  Speaker 4: remember this. I was always told you couldn't really confirm
• 43:26
  Speaker 4: an Alzheimer's diagnosis unless you cut open somebody's brain and
• 43:29
  Speaker 4: looked at it. So when I see all these diagnoses
• 43:32
  Speaker 4: going up, I think a lot of people are thinking
• 43:35
  Speaker 4: it's Alzheimer's disease. They want that prescription for an Alzheimer's
• 43:38
  Speaker 4: disease product, but do they really have Alzheimer's. And that's
• 43:41
  Speaker 4: why we've categorized our poster as Alzheimer's disease or dementia.
• 43:46
  Speaker 4: Because you can confirm a dementia that's pretty easy, it's
• 43:49
  Speaker 4: the actual Alzheimer's disease because there are other conditions that
• 43:53
  Speaker 4: are in the space that look like Alzheimer's that might
• 43:55
  Speaker 4: not be Alzheimer's. The other thing that we're seeing now,
• 44:00
  Speaker 4: and this helps differentiate between diseases, is the massive growth
• 44:04
  Speaker 4: of AI. You know, last at ASSEMBIA, I was fortunate
• 44:09
  Speaker 4: to be a guest host on the podcast and talk
• 44:13
  Speaker 4: with a nested knowledge about what they're doing to help
• 44:15
  Speaker 4: synthesize the pieces. We see a couple of exhibitors here
• 44:18
  Speaker 4: at this meeting. We're talking about using AI to streamline
• 44:22
  Speaker 4: the onboarding process for their patients, recognizing differentiating between different
• 44:28
  Speaker 4: types of conditions with EMR data. And that's all great,
• 44:31
  Speaker 4: and I think we need to continue to see that happen,
• 44:33
  Speaker 4: but we also need to see AI root out the evil.
• 44:37
  Speaker 4: And what I mean by the evil is there's so
• 44:38
  Speaker 4: much deep fake stuff. People can come to me all
• 44:41
  Speaker 4: the time and say, I saw it on the internet.
• 44:43
  Speaker 9: It must be true. Well is it?
• 44:45
  Speaker 4: And maybe we can turn some of these AI agents
• 44:48
  Speaker 4: into agents of change to actually go through and say,
• 44:51
  Speaker 4: you know what this is out there, it's not really valid,
• 44:54
  Speaker 4: it's not right, and how do we change.
• 44:57
  Speaker 9: The narrative on those pieces here?
• 44:59
  Speaker 4: You know, I think that's something that remains to be seen,
• 45:02
  Speaker 4: and I think as we continue to learn more from
• 45:04
  Speaker 4: these AI engines and what they can do, we're going
• 45:07
  Speaker 4: to see more growth in those areas. So the last
• 45:10
  Speaker 4: thing I want to talk about, Todd, and you are
• 45:12
  Speaker 4: at the forefront of this, believe it or not, Todd,
• 45:15
  Speaker 4: is the growth of podcasts. You know, when I started
• 45:19
  Speaker 4: interacting with you and meeting you about five years ago
• 45:22
  Speaker 4: at one of the first podcasts, you were the only
• 45:24
  Speaker 4: one out there in that space.
• 45:26
  Speaker 9: And what I keep seeing nowadays.
• 45:28
  Speaker 4: Is the growth and promulgation of podcasts for everybody. I
• 45:32
  Speaker 4: see people doing weekly podcasts of what their company is doing.
• 45:36
  Speaker 4: They're almost like an advertorial. We're disseminating different information as
• 45:40
  Speaker 4: we all do. That's why we run a podcast. But
• 45:43
  Speaker 4: I find that when I talk to people out in
• 45:45
  Speaker 4: the field, researchers, especially the younger people, they love soaking
• 45:50
  Speaker 4: up the podcast as a way to get their information.
• 45:52
  Speaker 4: And I know that Todd, you've been very advocating advocating
• 45:58
  Speaker 4: doing a peer review on a lot of podcastsials to
• 46:00
  Speaker 4: make sure it's the right material out there kind of
• 46:03
  Speaker 4: goes to that AI use to validate what we're hearing
• 46:06
  Speaker 4: and what we're seeing. And I'm just so glad to
• 46:09
  Speaker 4: see that we have people like you and your team
• 46:12
  Speaker 4: helping bring us to that next level of realization, communications
• 46:16
  Speaker 4: and then allowing us to benefit from the information and shared.
• 46:21
  Speaker 2: Thank you for mentioning that evidence space podcasting is a
• 46:25
  Speaker 2: trademark that we have out that we're solidifying the seal
• 46:29
  Speaker 2: and then we're coming up with peer reviewed standards that
• 46:33
  Speaker 2: originally started with the book written by doctor Bernadette Melnick
• 46:38
  Speaker 2: of OSU. She actually has a consultancy.
• 46:41
  Speaker 9: Now.
• 46:41
  Speaker 2: She wrote a book called evidence Space Practice. So we're
• 46:44
  Speaker 2: taking what is podcasting for the clinician, for the provider,
• 46:48
  Speaker 2: for the collaborative, and we're saying that content to truly
• 46:52
  Speaker 2: be evidence space should be peer reviewed. Anybody can buy
• 46:57
  Speaker 2: themselves a nice fancy microphone and jump on a podcasts
• 47:00
  Speaker 2: and say whatever they're going to say, and I encourage that.
• 47:03
  Speaker 2: But when you start going to higher levels and information
• 47:06
  Speaker 2: absorption and you expect to listen to something and know
• 47:09
  Speaker 2: that it's just as fortified as a journal article is,
• 47:12
  Speaker 2: then if you're gonna do that, it better be be
• 47:15
  Speaker 2: peer reviewed.
• 47:15
  Speaker 4: That's so great that we're getting there and that you're
• 47:18
  Speaker 4: driving that change. I remember back in the early nineties
• 47:22
  Speaker 4: when I became one of the first health economics people
• 47:25
  Speaker 4: at a pharm a company. At that point in time,
• 47:28
  Speaker 4: we would look at medline articles and almost every article
• 47:31
  Speaker 4: would say, therefore, this product is cost effective.
• 47:33
  Speaker 9: And I think that the journals and the.
• 47:36
  Speaker 4: Medical literature and the researchers finally said, wait a minute,
• 47:39
  Speaker 4: we have to really educate people about what cost effectiveness is.
• 47:45
  Speaker 4: What are we actually saying, what are we promoting, and
• 47:47
  Speaker 4: what are we allowing to be put in print because
• 47:50
  Speaker 4: we all want to have a valid peer reviewed journal. Well,
• 47:54
  Speaker 4: we're peer reviewing everything. If we're not peer reviewing that portion,
• 47:57
  Speaker 4: does it just mimic or make the rest of our
• 48:02
  Speaker 4: communications less important. So I think that's great the evidence
• 48:05
  Speaker 4: based movement here. We're going to still still continue to
• 48:09
  Speaker 4: put out information as often as we can in the
• 48:12
  Speaker 4: different forums to make sure it gets out there, and
• 48:14
  Speaker 4: we're gonna ask people to challenge us and we look
• 48:17
  Speaker 4: forward to that. And thanks Todd for keeping us on
• 48:20
  Speaker 4: that journey.
• 48:21
  Speaker 2: Well, thank you, Richard. Thanks for being part of the
• 48:23
  Speaker 2: NASP twenty twenty five here in Denver. I can't get
• 48:31
  Speaker 2: away from you. Like we were just at NACDS, Ryan
• 48:35
  Speaker 2: Clark key source, now we're at NSP.
• 48:39
  Speaker 10: Yeah, a lot of.
• 48:39
  Speaker 19: Travel lately, but you know, it's good, glad to see
• 48:42
  Speaker 19: you again.
• 48:44
  Speaker 10: You're doing the Lord's.
• 48:45
  Speaker 9: Work for sure.
• 48:47
  Speaker 2: I'm just trying to spread the word and that is,
• 48:48
  Speaker 2: you know, so many challenges in our pharmacy sector, and
• 48:53
  Speaker 2: there's one sector that always brings me hope even though
• 48:58
  Speaker 2: there's challenges, and that is specialty farm to see and
• 49:00
  Speaker 2: we are here at NASP in the booth in Denver,
• 49:04
  Speaker 2: it's been a great conference. You guys have been busy,
• 49:07
  Speaker 2: So why would key source. You're a you're a source
• 49:10
  Speaker 2: provider of products. You're getting people the products that they need.
• 49:15
  Speaker 2: You're helping to kind of backfill when there's instances of shortages.
• 49:21
  Speaker 2: You guys concentrate. I saw your booth at at NACDS
• 49:24
  Speaker 2: was always crowded. You have appointment after appointment, So why
• 49:28
  Speaker 2: is it important to be part of an ASP.
• 49:30
  Speaker 19: Yeah, you kind of hit the nail on the head
• 49:32
  Speaker 19: to start with. Is you know, so many pharmacies are
• 49:34
  Speaker 19: struggling right now. It's hard to stay profitable. It's hard
• 49:38
  Speaker 19: to you know, take care of your patients the way
• 49:40
  Speaker 19: you want to take care of them. And that's why
• 49:43
  Speaker 19: we come to places like an ASP and Sheila Arquette
• 49:46
  Speaker 19: and her team do a great job every year of
• 49:48
  Speaker 19: getting everybody you know in touch personally, you know, up close.
• 49:53
  Speaker 19: We don't have to book every five minute meetings like
• 49:56
  Speaker 19: some of these other conferences we go to, but it's
• 49:59
  Speaker 19: it's just great to see people face to face and
• 50:02
  Speaker 19: you can talk about your challenges, you know, over a
• 50:04
  Speaker 19: phone call or over a teams meeting all day, but
• 50:06
  Speaker 19: that face to face contact really helps people become comfortable
• 50:10
  Speaker 19: with you know, what can you really do to help
• 50:12
  Speaker 19: us out? And key Source we believe we can help
• 50:16
  Speaker 19: people beyond just the retail side of things. But there's
• 50:19
  Speaker 19: a lot of uh, specialty generics coming to market, you know,
• 50:22
  Speaker 19: every year there's more and more, and uh, you know,
• 50:25
  Speaker 19: we just try to do our best to help help
• 50:27
  Speaker 19: those supply gaps, help them save a little bit of
• 50:29
  Speaker 19: money where they can, and uh, you know, just create
• 50:33
  Speaker 19: great partnerships and a lot of those in a CDs
• 50:36
  Speaker 19: regional chains. It kind of goes hand in hand with
• 50:39
  Speaker 19: an EESP because a lot of.
• 50:40
  Speaker 10: Them have their own arm right, yeah they do. So
• 50:43
  Speaker 10: it's funny.
• 50:44
  Speaker 19: There's a there's a few people here we see, you know,
• 50:46
  Speaker 19: in an e CDs we have you know, long dinners
• 50:48
  Speaker 19: with right meetings and we come here like.
• 50:50
  Speaker 10: Hey guys, long time. No see it's been about two
• 50:53
  Speaker 10: and a half weeks, right, I never met exactly.
• 50:56
  Speaker 2: Well, that's the world, and we have to touch each
• 50:58
  Speaker 2: of the sectors because there's new wants is that are
• 51:00
  Speaker 2: very specific to specialty. I was really proud of the
• 51:03
  Speaker 2: three part series that Pharmacy Podcast Network invested in with
• 51:08
  Speaker 2: key Source and the one and only and craw we
• 51:13
  Speaker 2: should have like a crowd cheering.
• 51:17
  Speaker 10: You know, his head can't get any bigger than this.
• 51:19
  Speaker 2: Yes, just blow his head up somewhere. But Andy was
• 51:22
  Speaker 2: really dialing into specific challenges that you guys are really
• 51:27
  Speaker 2: helping pharmacies to overcome in procurement, in products that are
• 51:31
  Speaker 2: short out there you can't find and you're partnering with that.
• 51:35
  Speaker 2: So how does that tie into specialty pharmacy.
• 51:38
  Speaker 10: Yeah, so, and kudos Andy.
• 51:40
  Speaker 19: He's He's taught me pretty much everything I've known in
• 51:43
  Speaker 19: the last ten years.
• 51:43
  Speaker 10: I've been a key source.
• 51:45
  Speaker 19: And every time I come to these conferences, He's getting
• 51:49
  Speaker 19: pulled left and right about every ten feet because everyone
• 51:51
  Speaker 19: knows him and he knows this industry very well. And
• 51:55
  Speaker 19: as far as the specialty you know, arm goes, it
• 51:59
  Speaker 19: is is it's a whole different ballgame. It's a whole
• 52:02
  Speaker 19: different animal than you know some of the retail products
• 52:05
  Speaker 19: you see out there, And just to have access really
• 52:09
  Speaker 19: is a big key for some of these pharmacies because
• 52:12
  Speaker 19: there's a lot of maybe I shouldn't get too deep
• 52:15
  Speaker 19: into it, but a lot of vertical integration going.
• 52:17
  Speaker 10: On these days.
• 52:18
  Speaker 19: And to have someone else that can say all right.
• 52:22
  Speaker 19: We have great partners in relationships.
• 52:25
  Speaker 10: With these manufacturers and maybe they don't.
• 52:28
  Speaker 19: That's something we can, you know, kind of marry those
• 52:31
  Speaker 19: two together and give them access to a product or
• 52:34
  Speaker 19: better price into the product that normally they wouldn't have,
• 52:38
  Speaker 19: especially some of the you know, up and coming specialty
• 52:40
  Speaker 19: pharmacies people that are you know, just getting accredited and
• 52:43
  Speaker 19: just starting, you know, what they want to do.
• 52:46
  Speaker 10: It just helps to have that extra little.
• 52:49
  Speaker 19: You know, helping hand on the side, and that's what
• 52:51
  Speaker 19: Key Sources can provide.
• 52:53
  Speaker 2: So you're listening to the show, you are in that category,
• 52:56
  Speaker 2: either a startup specialty pharmacy or an expanding specialty farms parmacy,
• 53:00
  Speaker 2: reach out to the Key Source team tell them you
• 53:03
  Speaker 2: heard it here on the NSP podcast. Give a shout
• 53:06
  Speaker 2: out to John Cena of the Pharmacy World and New Crawford.
• 53:15
  Speaker 2: We'll just you have to have like a SoundBite that
• 53:17
  Speaker 2: we'll just do that over and over again.
• 53:19
  Speaker 10: New craw for you've got to be good at editing.
• 53:22
  Speaker 10: You can throw something, We'll.
• 53:23
  Speaker 2: Get Brady to do it for sure. Hey, thank you
• 53:26
  Speaker 2: for spending time with me here at the NSP podcast.
• 53:29
  Speaker 10: It's been great. Appreciate you buddy.
• 53:34
  Speaker 20: Hi, this is Shila, our cat and you are listening
• 53:37
  Speaker 20: to the NSP podcast.
• 53:41
  Speaker 2: Hey thereon wrapping up the show. This is the CEO
• 53:45
  Speaker 2: of the n EESP. Excited to have you back, Sheila.
• 53:48
  Speaker 2: What an amazing event.
• 53:50
  Speaker 20: Thank you so much. Todd, Yes, it was. It's so uh,
• 53:52
  Speaker 20: it's so exciting. We we spend an entire year preparing
• 53:55
  Speaker 20: for this conference, and when we get on site and
• 53:58
  Speaker 20: we get to see it all come together and to
• 54:01
  Speaker 20: see the experience that our attendees and our sponsor and
• 54:04
  Speaker 20: exhibitors are having, it's super, super exciting and very rewarding.
• 54:08
  Speaker 2: Yeah, there's so much going on. I was so impressed
• 54:12
  Speaker 2: with how much activity coming out of the sessions was
• 54:16
  Speaker 2: pouring into the exhibit hall, and it was very specific
• 54:19
  Speaker 2: to some of those vendors who are strategically dialing in
• 54:23
  Speaker 2: what's happening in specialty pharmacy. AI was all over the place,
• 54:28
  Speaker 2: but for the for the first time, it's making more
• 54:32
  Speaker 2: concrete sense and more connection, and it's actually being used.
• 54:36
  Speaker 2: It's not just like we're talking about what's coming we're
• 54:38
  Speaker 2: at literally we're talking about what they're actually doing today.
• 54:41
  Speaker 2: So that was amazing. Any any highlights that you kind
• 54:44
  Speaker 2: of wanted to to mention to our NASP podcast listeners.
• 54:48
  Speaker 20: Sure, everybody always asks me leading up to the conference,
• 54:51
  Speaker 20: what's this year's theme? What's your this year's theme? And
• 54:54
  Speaker 20: we typically don't set a theme. But as I was
• 54:56
  Speaker 20: walking around and I was listening to folks, and you know,
• 54:59
  Speaker 20: after our key note presentations and the buzz after that,
• 55:03
  Speaker 20: it was it was all about connection, right, And everybody
• 55:07
  Speaker 20: really touched on that. If I could have planned it,
• 55:09
  Speaker 20: I couldn't have planned it better because it all came together.
• 55:12
  Speaker 20: And it's just about how how important making those meaningful
• 55:15
  Speaker 20: connections are and how we come together, we collaborate, we
• 55:20
  Speaker 20: work together to enhance patient care. One of our attendees
• 55:23
  Speaker 20: told me that meaningful connection was the heartbeat of this conference,
• 55:26
  Speaker 20: and I love that, and so we did.
• 55:28
  Speaker 2: We had so much going on, You're right.
• 55:29
  Speaker 20: The educational sessions, I mean just incredible, the speaker faculty everything,
• 55:34
  Speaker 20: you know, all all that they did to bring right
• 55:38
  Speaker 20: the latest evidence based medicine and practices and changes, and
• 55:43
  Speaker 20: you know, all of our sponsors and exhibitors. The exhibit
• 55:46
  Speaker 20: hall was incredible. You know, we have you know, we
• 55:49
  Speaker 20: do a little bit of fund throughout the conference. We
• 55:51
  Speaker 20: also were able to give back and we hosted Tina's
• 55:55
  Speaker 20: Warriors and packed Hope Care for those battling breast cancers.
• 56:00
  Speaker 20: So I think there was a little mix of something
• 56:02
  Speaker 20: for everybody, or at least I'm hoping yes.
• 56:04
  Speaker 2: I picked that up, and I was excited to also
• 56:07
  Speaker 2: see how much collaboration that was going on in the
• 56:11
  Speaker 2: exhibit hall with even other vendors that were getting together
• 56:14
  Speaker 2: with people that were there that were combining kind of
• 56:18
  Speaker 2: some of their solutions, and some of that was happening
• 56:21
  Speaker 2: in the NASP podcast booth too. I did hear a
• 56:26
  Speaker 2: lot of follow up more than ever on the Specialty
• 56:30
  Speaker 2: Pharmacist Certification program and how important that is for really
• 56:35
  Speaker 2: the future of specialty pharmacy to really start digging down
• 56:38
  Speaker 2: into specific disease conditions and rare diseases that pharmacists are
• 56:42
  Speaker 2: part of those treatment teams. And you were talking about
• 56:46
  Speaker 2: evidence based and of course we're coming up with a
• 56:49
  Speaker 2: standard evidence based podcasting to ensure what podcasts you're listening
• 56:52
  Speaker 2: to have been peer reviewed and they're based on good stuff.
• 56:56
  Speaker 2: And that's just another element of bringing additional opportunity to
• 57:02
  Speaker 2: shout out to all those pharmacists out there who are saying, Hey,
• 57:05
  Speaker 2: I'd really like to dig deeper into hematology or a
• 57:09
  Speaker 2: blood disorder or really dig it, so talk to us
• 57:12
  Speaker 2: about that.
• 57:12
  Speaker 20: Sure, And so, you know, another shout out to the
• 57:15
  Speaker 20: founders of NASP right way back in twenty ten to
• 57:18
  Speaker 20: twenty eleven, when they started kind of talking about we
• 57:20
  Speaker 20: need an association, they knew how important certification was going
• 57:24
  Speaker 20: to be in the absence of a definition of specialty
• 57:27
  Speaker 20: pharmacy and we still struggle with that today. Right we
• 57:29
  Speaker 20: have a general consensus, but we don't have and establish
• 57:32
  Speaker 20: an accepted definition. So certification is so important so that
• 57:36
  Speaker 20: those pharmacists can differentiate themselves right from other pharmacists who
• 57:41
  Speaker 20: are you know, community pharmacy experts and hospital pharmacy experts.
• 57:44
  Speaker 20: And so I think we have definitely turned our eye
• 57:48
  Speaker 20: to certification and certificate programs as well. At the end
• 57:52
  Speaker 20: of this year and the beginning of twenty twenty six,
• 57:54
  Speaker 20: we're going to launch a certificate program for specialty pharmacy technicians.
• 57:59
  Speaker 20: We're also working with some friends in Canada and launching
• 58:03
  Speaker 20: a certificate program for those folks as well as new
• 58:06
  Speaker 20: grands right who are very interested in getting into specialty
• 58:10
  Speaker 20: pharmacy me not fulfill all the criteria to sit for
• 58:13
  Speaker 20: the for the CSP exam and earn that credential. So
• 58:16
  Speaker 20: it's kind of like a bridge. So definitely focused on,
• 58:20
  Speaker 20: you know, differentiating these folks who are you know, the
• 58:24
  Speaker 20: stars of our industry.
• 58:25
  Speaker 2: So the place I spend most of my time just
• 58:28
  Speaker 2: because of our schedules and how busy things get, is
• 58:30
  Speaker 2: on the exhibit floor and I love being there. It's
• 58:32
  Speaker 2: my favorite spot. And we got a bunch of interviews
• 58:37
  Speaker 2: that have been part of this incredible series. A shout
• 58:39
  Speaker 2: out to all of our guests who were part of
• 58:41
  Speaker 2: the NESP Podcast twenty twenty five. Thank you so much
• 58:44
  Speaker 2: for being part of it. Is there any organizations out there,
• 58:48
  Speaker 2: Sheila that you're like, wow, they really stepped up to
• 58:51
  Speaker 2: help us kind of like pull this all together because
• 58:53
  Speaker 2: our sponsors and are the exhibits, the companies that are
• 58:57
  Speaker 2: investing are part of that ecosystem and I rely on
• 59:02
  Speaker 2: them to bring me the information that they're kind of
• 59:04
  Speaker 2: helping to build out.
• 59:05
  Speaker 20: So absolutely, I mean, of course, right those organizations who
• 59:09
  Speaker 20: were like, you know, our Diamond and Ruby and Sapphire
• 59:11
  Speaker 20: sponsors incredible, right that you know they step up and
• 59:16
  Speaker 20: you know, they bring these exhibits or they sponsor some
• 59:18
  Speaker 20: of the activities, they make it possible for us to
• 59:20
  Speaker 20: host them. And I think this year we have you know,
• 59:23
  Speaker 20: we had so many new exhibitors. But then we're also
• 59:26
  Speaker 20: those folks that have been with us right for the
• 59:28
  Speaker 20: last you know, five, six, seven, eight years, they continue
• 59:31
  Speaker 20: to come back and they continue to round out that offering,
• 59:34
  Speaker 20: and so just thankful to everybody, right, because it's sometimes
• 59:39
  Speaker 20: it's hard to know the investment somebody makes, right maybe
• 59:42
  Speaker 20: is you know, the dollar amount is not as big
• 59:45
  Speaker 20: as somebody else, but it's still is a sacrifice, right
• 59:48
  Speaker 20: or it's still like it's the investment that they can make.
• 59:50
  Speaker 20: So we are so thankful for all of that and
• 59:53
  Speaker 20: just for bringing that energy, for bringing that knowledge, for
• 59:56
  Speaker 20: interacting with you know, their fellow sponsors and exhibitors, but
• 59:59
  Speaker 20: then also all of the attendees. So I think this
• 1:00:02
  Speaker 20: year it was just such an incredible group of people
• 1:00:04
  Speaker 20: that came together to make it possible. We couldn't do
• 1:00:07
  Speaker 20: it without any of them.
• 1:00:10
  Speaker 2: Yeah, and that makes me excited about what's you know,
• 1:00:12
  Speaker 2: what's coming and the momentum that we're coming out of
• 1:00:16
  Speaker 2: the twenty twenty five event, bringing us into the wrap
• 1:00:20
  Speaker 2: up of twenty twenty five and then preparing and starting
• 1:00:23
  Speaker 2: to think about, you know, how do we level up,
• 1:00:25
  Speaker 2: how do we keep going? How do we serve our
• 1:00:27
  Speaker 2: patients even better? You know, For us, I'm just so
• 1:00:32
  Speaker 2: thankful for sponsors to invest in helping us cover the
• 1:00:37
  Speaker 2: show and be able to kind of dig down into
• 1:00:40
  Speaker 2: content and deliver to you the listener. So tell us
• 1:00:43
  Speaker 2: about twenty twenty six. What's coming for the NESPS twenty
• 1:00:48
  Speaker 2: twenty six event.
• 1:00:49
  Speaker 13: Sure, so.
• 1:00:52
  Speaker 20: We really rely on our members and our previous attendees
• 1:00:56
  Speaker 20: to help guide that, right, what is it that is
• 1:00:58
  Speaker 20: impacting your business?
• 1:01:00
  Speaker 16: What do you need to learn more about?
• 1:01:02
  Speaker 20: What do you think is cutting edge?
• 1:01:03
  Speaker 3: Right?
• 1:01:04
  Speaker 20: We are Education Committee does an incredible job right of
• 1:01:07
  Speaker 20: taking in all of that feedback that we receive, looking
• 1:01:12
  Speaker 20: at their own businesses, right, and their own areas of expertise,
• 1:01:16
  Speaker 20: trying to trying to project what's happening on the horizon.
• 1:01:18
  Speaker 2: We have so much going on.
• 1:01:19
  Speaker 20: Within healthcare, and so it's definitely, you know, definitely a
• 1:01:23
  Speaker 20: work in progress. I think this year the workshops that
• 1:01:25
  Speaker 20: we hosted were very well received. You know, we talk
• 1:01:28
  Speaker 20: about accreditation, We talk about the art of infusion. We
• 1:01:32
  Speaker 20: you know, specialty pharmacy, law, next gen intelligence or technology,
• 1:01:36
  Speaker 20: and like you said, the role of AI hospital health
• 1:01:40
  Speaker 20: system specially pharmacy right continues to be incredibly popular and
• 1:01:44
  Speaker 20: continues to expand. And so you know, as we look
• 1:01:49
  Speaker 20: to the future, we really rely on those folks that
• 1:01:51
  Speaker 20: are coming right, investing their time, investing their financial resources
• 1:01:54
  Speaker 20: to tell us what they need. We also are rebrand
• 1:02:00
  Speaker 20: the NSP Annual Meeting and Expo. We are going to
• 1:02:03
  Speaker 20: retire that name effective now, and as we look to
• 1:02:06
  Speaker 20: the future and all that the meeting offers, we are
• 1:02:11
  Speaker 20: going to call our conference Inspire and so each of
• 1:02:14
  Speaker 20: those letters stands for something. It's innovation, networking of course,
• 1:02:18
  Speaker 20: specialty pharmacy in the middle, insights, research and education, and
• 1:02:22
  Speaker 20: so that is what we are focused on bringing right
• 1:02:25
  Speaker 20: to this meeting when we all come together to learn
• 1:02:28
  Speaker 20: and share best practices into network and so you will look,
• 1:02:31
  Speaker 20: you'll see that right, We're going to have that everywhere.
• 1:02:33
  Speaker 20: We're going to continue to try to introduce that and
• 1:02:36
  Speaker 20: we're just trying to have a little bit of a
• 1:02:38
  Speaker 20: differentiation between NASP the organization and then the NSP Annual
• 1:02:42
  Speaker 20: meeting and expo, and sometimes it gets a little bit
• 1:02:44
  Speaker 20: confused and confounded. So while the conference is a huge
• 1:02:49
  Speaker 20: part of who we are and what we do, it's
• 1:02:51
  Speaker 20: not our entire identity.
• 1:02:52
  Speaker 2: L I love that. I love that it actually inspires
• 1:02:55
  Speaker 2: me as well. And we'll be covering that event as
• 1:02:58
  Speaker 2: the inspire a cat launches off and really digs down
• 1:03:02
  Speaker 2: into each of what that what that acronym means and
• 1:03:06
  Speaker 2: looking for leaders in specialty pharmacy and looking for pharmacists
• 1:03:10
  Speaker 2: that are out there. If you're part of this event
• 1:03:12
  Speaker 2: and you want to reach out to Shila, you will
• 1:03:14
  Speaker 2: have a story to tell. The NASP podcasts really into
• 1:03:19
  Speaker 2: those stories and it's been wonderful to have you part
• 1:03:21
  Speaker 2: of the network. All Right, Sheila, thank you so much
• 1:03:24
  Speaker 2: for rounding out the NSP podcasts twenty twenty five. We
• 1:03:29
  Speaker 2: appreciate you.
• 1:03:30
  Speaker 20: Awesome. I appreciate you too, and everybody. Market calendar September
• 1:03:33
  Speaker 20: twenty second through twenty fifth, National Harbor, Maryland at the
• 1:03:37
  Speaker 20: Gaylord National Resort and Convention Center.
• 1:03:39
  Speaker 2: Thank you, thank you.